@article{damaj_g_impact_2012,
title = {Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Societe Francaise de Greffe de Moelle et de Therapie-Cellulaire and the Groupe-Francophone des Myelodysplasies},
volume = {30},
issn = {0732-183X},
url = {http://www.ncbi.nlm.nih.gov/pubmed/23109707},
DOI = {10.1200/JCO.2012.44.3499},
Language = {English},
Journal = {J. Clin. Oncol.},
author = {{Damaj G} and {Duhamel A} and {Robin M} and {Beguin Y} and {Michallet M} and {Mohty M} and {Vigouroux S} and {Bories P} and {Garnier A} and {El Cheikh J} and {Bulabois CE} and {Huynh A} and {Bay JO} and {Legrand F} and {Deconinck E} and {Fegueux N} and {Clement L} and {Dauriac C} and {Maillard N} and {Cornillon J} and {Ades L} and {Guillerm G} and {Schmidt-Tanguy A} and {Marjanovic Z} and {Park S} and {Rubio MT} and {Marolleau JP} and {Garnier F} and {Fenaux P} and {Yakoub-Agha I}},
year = {2012},
keywords = {Antimetabolites, Antineoplastic/adverse effects, Antimetabolites, Antineoplastic/therapeutic use*, Azacitidine/adverse effects, Azacitidine/therapeutic use*, Combined Modality Therapy, Female, Hematopoietic Stem Cell Transplantation/methods*, Humans, Induction Chemotherapy, Male, Middle Aged, Myelodysplastic Syndromes/drug therapy*, Myelodysplastic Syndromes/etiology, Myelodysplastic Syndromes/surgery*, Retrospective Studies, Transplantation, Homologous/methods, Treatment Outcome},
pages = {4533-4540}
}

{"_id":"uehRxuJnjikKktuw6","bibbaseid":"damajg-duhamela-robinm-beguiny-michalletm-mohtym-vigourouxs-boriesp-etal-impactofazacitidinebeforeallogeneicstemcelltransplantationformyelodysplasticsyndromesastudybythesocietefrancaisedegreffedemoelleetdetherapiecellulaireandthegroupefrancophonedesmyelodysplasies-2012","authorIDs":[],"author_short":["Damaj G","Duhamel A","Robin M","Beguin Y","Michallet M","Mohty M","Vigouroux S","Bories P","Garnier A","El Cheikh J","Bulabois CE","Huynh A","Bay JO","Legrand F","Deconinck E","Fegueux N","Clement L","Dauriac C","Maillard N","Cornillon J","Ades L","Guillerm G","Schmidt-Tanguy A","Marjanovic Z","Park S","Rubio MT","Marolleau JP","Garnier F","Fenaux P","Yakoub-Agha I"],"bibdata":{"bibtype":"article","type":"article","title":"Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Societe Francaise de Greffe de Moelle et de Therapie-Cellulaire and the Groupe-Francophone des Myelodysplasies","volume":"30","issn":"0732-183X","url":"http://www.ncbi.nlm.nih.gov/pubmed/23109707","doi":"10.1200/JCO.2012.44.3499","language":"English","journal":"J. Clin. Oncol.","author":[{"firstnames":[],"propositions":[],"lastnames":["Damaj G"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Duhamel A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Robin M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Beguin Y"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Michallet M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Mohty M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Vigouroux S"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Bories P"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Garnier A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["El Cheikh J"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Bulabois CE"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Huynh A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Bay JO"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Legrand F"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Deconinck E"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Fegueux N"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Clement L"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Dauriac C"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Maillard N"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Cornillon J"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Ades L"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Guillerm G"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Schmidt-Tanguy A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Marjanovic Z"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Park S"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Rubio MT"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Marolleau JP"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Garnier F"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Fenaux P"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Yakoub-Agha I"],"suffixes":[]}],"year":"2012","keywords":"Antimetabolites, Antineoplastic/adverse effects, Antimetabolites, Antineoplastic/therapeutic use*, Azacitidine/adverse effects, Azacitidine/therapeutic use*, Combined Modality Therapy, Female, Hematopoietic Stem Cell Transplantation/methods*, Humans, Induction Chemotherapy, Male, Middle Aged, Myelodysplastic Syndromes/drug therapy*, Myelodysplastic Syndromes/etiology, Myelodysplastic Syndromes/surgery*, Retrospective Studies, Transplantation, Homologous/methods, Treatment Outcome","pages":"4533-4540","bibtex":"@article{damaj_g_impact_2012,\r\ntitle = {Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Societe Francaise de Greffe de Moelle et de Therapie-Cellulaire and the Groupe-Francophone des Myelodysplasies},\r\nvolume = {30},\r\nissn = {0732-183X},\r\nurl = {http://www.ncbi.nlm.nih.gov/pubmed/23109707},\r\nDOI = {10.1200/JCO.2012.44.3499},\r\nLanguage = {English},\r\nJournal = {J. Clin. Oncol.},\r\nauthor = {{Damaj G} and {Duhamel A} and {Robin M} and {Beguin Y} and {Michallet M} and {Mohty M} and {Vigouroux S} and {Bories P} and {Garnier A} and {El Cheikh J} and {Bulabois CE} and {Huynh A} and {Bay JO} and {Legrand F} and {Deconinck E} and {Fegueux N} and {Clement L} and {Dauriac C} and {Maillard N} and {Cornillon J} and {Ades L} and {Guillerm G} and {Schmidt-Tanguy A} and {Marjanovic Z} and {Park S} and {Rubio MT} and {Marolleau JP} and {Garnier F} and {Fenaux P} and {Yakoub-Agha I}},\r\nyear = {2012},\r\nkeywords = {Antimetabolites, Antineoplastic/adverse effects, Antimetabolites, Antineoplastic/therapeutic use*, Azacitidine/adverse effects, Azacitidine/therapeutic use*, Combined Modality Therapy, Female, Hematopoietic Stem Cell Transplantation/methods*, Humans, Induction Chemotherapy, Male, Middle Aged, Myelodysplastic Syndromes/drug therapy*, Myelodysplastic Syndromes/etiology, Myelodysplastic Syndromes/surgery*, Retrospective Studies, Transplantation, Homologous/methods, Treatment Outcome},\r\npages = {4533-4540}\r\n}\r\n\r\n","author_short":["Damaj G","Duhamel A","Robin M","Beguin Y","Michallet M","Mohty M","Vigouroux S","Bories P","Garnier A","El Cheikh J","Bulabois CE","Huynh A","Bay JO","Legrand F","Deconinck E","Fegueux N","Clement L","Dauriac C","Maillard N","Cornillon J","Ades L","Guillerm G","Schmidt-Tanguy A","Marjanovic Z","Park S","Rubio MT","Marolleau JP","Garnier F","Fenaux P","Yakoub-Agha I"],"key":"damaj_g_impact_2012","id":"damaj_g_impact_2012","bibbaseid":"damajg-duhamela-robinm-beguiny-michalletm-mohtym-vigourouxs-boriesp-etal-impactofazacitidinebeforeallogeneicstemcelltransplantationformyelodysplasticsyndromesastudybythesocietefrancaisedegreffedemoelleetdetherapiecellulaireandthegroupefrancophonedesmyelodysplasies-2012","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/23109707"},"keyword":["Antimetabolites","Antineoplastic/adverse effects","Antimetabolites","Antineoplastic/therapeutic use*","Azacitidine/adverse effects","Azacitidine/therapeutic use*","Combined Modality Therapy","Female","Hematopoietic Stem Cell Transplantation/methods*","Humans","Induction Chemotherapy","Male","Middle Aged","Myelodysplastic Syndromes/drug therapy*","Myelodysplastic Syndromes/etiology","Myelodysplastic Syndromes/surgery*","Retrospective Studies","Transplantation","Homologous/methods","Treatment Outcome"],"downloads":0},"bibtype":"article","biburl":"https://pro.univ-lille.fr/fileadmin/user_upload/pages_pros/patrick_devos/duhamel.bib","creationDate":"2019-06-21T09:30:55.093Z","downloads":0,"keywords":["antimetabolites","antineoplastic/adverse effects","antimetabolites","antineoplastic/therapeutic use*","azacitidine/adverse effects","azacitidine/therapeutic use*","combined modality therapy","female","hematopoietic stem cell transplantation/methods*","humans","induction chemotherapy","male","middle aged","myelodysplastic syndromes/drug therapy*","myelodysplastic syndromes/etiology","myelodysplastic syndromes/surgery*","retrospective studies","transplantation","homologous/methods","treatment outcome"],"search_terms":["impact","azacitidine","before","allogeneic","stem","cell","transplantation","myelodysplastic","syndromes","study","societe","francaise","greffe","moelle","therapie","cellulaire","groupe","francophone","des","myelodysplasies","damaj g","duhamel a","robin m","beguin y","michallet m","mohty m","vigouroux s","bories p","garnier a","el cheikh j","bulabois ce","huynh a","bay jo","legrand f","deconinck e","fegueux n","clement l","dauriac c","maillard n","cornillon j","ades l","guillerm g","schmidt-tanguy a","marjanovic z","park s","rubio mt","marolleau jp","garnier f","fenaux p","yakoub-agha i"],"title":"Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Societe Francaise de Greffe de Moelle et de Therapie-Cellulaire and the Groupe-Francophone des Myelodysplasies","year":2012,"dataSources":["Tt6zYqvN5kE3wbwiR"]}